English
Specials
Premium
My Alerts

Amgen

SYMBOL:AMGN|SECTOR:Health Care|DERIVED:CFD
i
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices are indicative only and not appropriate for trading purposes. Therefore Moneycontrol doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
$
2
2
1
1
.
4
4
8
8
3
3
16.32 (4.44%)

As on 07 Feb, 2026 | 02:29 IST

Day Range
369.60
385.10
LH
52 Week Range
261.50
385.10
LH
Advance Chart
Open375.16
Previous Close367.80
Beta-0.22
High385.10
Low369.60
TTM EPS See historical trend   21.87(+13.79% YoY)
52 Week High385.10
52 Week Low261.50
TTM PE See historical trend    17.56(Low PE)
Mkt. Cap ($ Billion)206.48
Dividend Yield3.33

Advanced Chart

*Delayed by 20 seconds

MC Technicals

Technical rating
i
This represents current trend.
Click here  for disclaimer.
Trend
Very Bullish
See Details  
Historical Rating  
Moving AveragesBullish
Technical IndicatorsBullish
Moving Averages CrossoversBullish

Pivot levels

TypeR1R2R3PPS1S2S3
Classic373.36 378.93 383.08369.21 363.64 359.49 353.92
Fibonacci372.92 375.21 378.93369.21 365.49 363.20 359.49
Camarilla368.69 369.58 370.47369.21 366.91 366.02 365.13

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Moving Averages
Days
5360.28
10352.96
20343.08
50335.31
100317.96
200303.01

Returns

Price Performance
1 Week11.42%
1 Month16.90%
3 Months31.55%
YTD17.34%
1 Year35.23%
3 Years52.84%

Financialsin million $

Peers

NamePrice ($)Change%M.Cap(Billion $)TTM PETTM EPSDY52 wk high/lowTechnical Rating
Eli Lilly1,056.703.511,005.6148.1021.990.741,133.95/623.99-2.05Bullish
J&J240.130.98578.3222.2210.802.50240.92/143.6815.97Very Bullish
AbbVie223.432.01394.6923.639.453.49244.80/164.59-2.78Bullish
Merck121.881.78308.6814.098.653.86122.65/73.3514.91Very Bullish
Amgen384.124.44206.4817.5621.873.33385.10/261.5016.90Very Bullish
+ See More

Market news

Dow Jones Industrial Average breaks 50,000 level for first time

February 7, 2026 9:16 AM
Show More

About the company

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine) and AVSOLA (infliximab-axxq). It focuses on human therapeutics for the treatment of serious illness in the areas of inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience.